These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37031211)

  • 21. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection.
    Vrijsen S; Houdou M; Cascalho A; Eggermont J; Vangheluwe P
    Annu Rev Biochem; 2023 Jun; 92():435-464. PubMed ID: 37018845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.
    Tan J; Zhang T; Jiang L; Chi J; Hu D; Pan Q; Wang D; Zhang Z
    J Biol Chem; 2011 Aug; 286(34):29654-62. PubMed ID: 21724849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The strategic function of the P5-ATPase ATP13A2 in toxic waste disposal.
    de Tezanos Pinto F; Adamo HP
    Neurochem Int; 2018 Jan; 112():108-113. PubMed ID: 29169913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A lipid switch unlocks Parkinson's disease-associated ATP13A2.
    Holemans T; Sørensen DM; van Veen S; Martin S; Hermans D; Kemmer GC; Van den Haute C; Baekelandt V; Günther Pomorski T; Agostinis P; Wuytack F; Palmgren M; Eggermont J; Vangheluwe P
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9040-5. PubMed ID: 26134396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel mutations in ATP13A2 associated with mixed neurological presentations and iron toxicity due to nonsense-mediated decay.
    Kırımtay K; Temizci B; Gültekin M; Yapıcı Z; Karabay A
    Brain Res; 2021 Jan; 1750():147167. PubMed ID: 33091395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHO cells expressing the human P₅-ATPase ATP13A2 are more sensitive to the toxic effects of herbicide paraquat.
    Pinto Fde T; Corradi GR; Hera DP; Adamo HP
    Neurochem Int; 2012 Feb; 60(3):243-8. PubMed ID: 22265822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.
    Ramonet D; Podhajska A; Stafa K; Sonnay S; Trancikova A; Tsika E; Pletnikova O; Troncoso JC; Glauser L; Moore DJ
    Hum Mol Genet; 2012 Apr; 21(8):1725-43. PubMed ID: 22186024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson disease related ATP13A2 evolved early in animal evolution.
    Sørensen DM; Holemans T; van Veen S; Martin S; Arslan T; Haagendahl IW; Holen HW; Hamouda NN; Eggermont J; Palmgren M; Vangheluwe P
    PLoS One; 2018; 13(3):e0193228. PubMed ID: 29505581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death.
    Ugolino J; Fang S; Kubisch C; Monteiro MJ
    Hum Mol Genet; 2011 Sep; 20(18):3565-77. PubMed ID: 21665991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson's Disease Model.
    Gao H; Sun H; Yan N; Zhao P; Xu H; Zheng W; Zhang X; Wang T; Guo C; Zhong M
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity.
    Rinaldi DE; Corradi GR; Cuesta LM; Adamo HP; de Tezanos Pinto F
    Biochim Biophys Acta; 2015 Aug; 1848(8):1646-55. PubMed ID: 25912790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion.
    Wang R; Tan J; Chen T; Han H; Tian R; Tan Y; Wu Y; Cui J; Chen F; Li J; Lv L; Guan X; Shang S; Lu J; Zhang Z
    J Cell Biol; 2019 Jan; 218(1):267-284. PubMed ID: 30538141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.
    Kong SM; Chan BK; Park JS; Hill KJ; Aitken JB; Cottle L; Farghaian H; Cole AR; Lay PA; Sue CM; Cooper AA
    Hum Mol Genet; 2014 Jun; 23(11):2816-33. PubMed ID: 24603074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation.
    Fong CY; Rolfs A; Schwarzbraun T; Klein C; O'Callaghan FJ
    Eur J Paediatr Neurol; 2011 May; 15(3):271-5. PubMed ID: 21316993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered apoptosis regulation in Kufor-Rakeb syndrome patients with mutations in the ATP13A2 gene.
    Radi E; Formichi P; Di Maio G; Battisti C; Federico A
    J Cell Mol Med; 2012 Aug; 16(8):1916-23. PubMed ID: 22117566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival.
    Lopes da Fonseca T; Correia A; Hasselaar W; van der Linde HC; Willemsen R; Outeiro TF
    Brain Res Bull; 2013 Jan; 90():118-26. PubMed ID: 23123961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of ATP13A2 impairs glycolytic function in Kufor-Rakeb syndrome patient-derived cell models.
    Park JS; Koentjoro B; Davis RL; Sue CM
    Parkinsonism Relat Disord; 2016 Jun; 27():67-73. PubMed ID: 27039055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.
    van Veen S; Sørensen DM; Holemans T; Holen HW; Palmgren MG; Vangheluwe P
    Front Mol Neurosci; 2014; 7():48. PubMed ID: 24904274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.